A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia

Clinical trial NCT01179217 · COMPLETED

Trial details

NCT number: NCT01179217
Sponsor: Emmaus Medical, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Sickle Cell Anemia Sickle ß0-Thalassemia

Start date: 2010-05-01
Primary completion: 2014-03-01
Enrollment: 230

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.